Login / Signup
Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis.
Yifei Tan
Yongjie Zhou
Wei Zhang
Zhenru Wu
Qing Xu
Qiong Wu
Jian Yang
Tao Lv
Lvnan Yan
Hong Luo
Yujun Shi
Jiayin Yang
Published in:
Cellular oncology (Dordrecht) (2024)
Our results indicate that RPG prevented the development and progression of HCC via alteration of FOXO3/lumican/p53 axis.
Keyphrases
</>
transcription factor
signaling pathway
pi k akt